Guohao Dai,
Associate Professor, Department of Bioengineering,
Northeastern University
Dr. Dai is currently an Associate Professor in the Department of Bioengineering at Northeastern University. Dr. Dai received his B.S. and M.S. in Mechanical Engineering from Peking University, Ph.D. in Biomedical Engineering from MIT’s HST Program (Harvard-MIT Division of Health Science and Technology). He completed his Post-doctoral training in Vascular Biology at Harvard Medical School (Center for Excellence in Vascular Biology). Current researches in his lab focus on the 3-D bioprinting technology, stem cells and vascular bioengineering, and are funded by major grants from NSF, NIH and American Heart Association. Dr. Dai received the Scientist Development Award from American Heart Association, Faculty Early Career Award from National Science Foundation, Rising Star Award from Biomedical Engineering Society, Institute’s Faculty Career Award (RPI), and College of Engineering Faculty Fellow (Northeastern). He is the elected Fellow of American Heart Association (FAHA).
3D Bioprinted Vascularized Glioblastoma Model
Tuesday, 18 August 2020 at 10:30
Add to Calendar ▼2020-08-18 10:30:002020-08-18 11:30:00Europe/London3D Bioprinted Vascularized Glioblastoma Model3D-Printing and Biofabrication 2020 in Boston, USABoston, USASELECTBIOenquiries@selectbiosciences.com
Glioblastoma (GBM), the most malignant brain cancer, remains deadly despite wide-margin surgical resection and concurrent chemo- & radiation therapies. Two pathological hallmarks of GBM are diffusive invasion along brain vasculature, and presence of therapy-resistant tumor initiating stem cells. Deconstructing the underlying mechanisms of GBM-vascular interaction may add a new therapeutic direction to curtail GBM progression. However, the lack of proper 3D models that recapitulate GBM hallmarks restricts investigating cell-cell/cell-molecular interactions in tumor microenvironments. In this study, we created GBM-vascular niche models through 3D bioprinting containing patient-derived glioma stem cells (GSCs), human brain microvascular endothelial cells (hBMVECs) cells, pericytes, astrocytes and various hydrogels to model glioma/endothelial cell-cell interactions in 3D. In summary we have created GBM-vascular niche models that can recapitulate various GBM characteristics such as cancer stemness, tumor type-specific invasion patterns, and drug responses with therapeutic resistance. Our models have a great potential in investigating patient-specific tumor behaviors under chemo-/radio-therapy conditions and consequentially helping to tailor personalized treatment strategy. The model platform is capable of modifying multiples variables including ECMs, cell types, vascular structures, and dynamic culture condition. Thus, it can be adapted to other biological systems and serve as a valuable tool for generating customized tumor microenvironments.
Add to Calendar ▼2020-08-17 00:00:002020-08-18 00:00:00Europe/London3D-Printing and Biofabrication 20203D-Printing and Biofabrication 2020 in Boston, USABoston, USASELECTBIOenquiries@selectbiosciences.com
Add to Calendar ▼2020-08-18 10:30:002020-08-18 11:30:00Europe/London3D Bioprinted Vascularized Glioblastoma Model3D-Printing and Biofabrication 2020 in Boston, USABoston, USASELECTBIOenquiries@selectbiosciences.com
